Pharmaceutical Technology & Biosimilars

Pharmaceutical Technology & Biosimilars Photo

The application of systematic information or technology to pharmacy, pharmacology, and the pharmaceutical manufacturing is termed as Pharmaceutical technology. These products are made by transforming chemical compounds with useful things on the human body into high-quality dosage forms that can appropriately exhibit effects against disease.A biosimilar is biologic manufactured goods that is similar, but not the same, to a reference product, and therefore requires separate marketing approval upon patent expiration of the reference product. Biosimilars are not generic versions of biologics. Many of the countries in these areas do not have rigorous testing requirements and strict standards for approving drugs that are claimed to be similar to reference products.

  • Drug Development
  • Experimental Therapeutics
  • Pharmaceutical Formulation Development
  • Pharmaceutical Biotechnology
  • Regulatory Approach for Biosimilars
  • Emerging Biosimilars in Therapeutics
  • Clinical Development of Biosimilars
  • Globalization of Biosimilars
  • Biosimilars Research Pipeline
  • Biosimilars Analytical Strategies
  • Bioequivalence Assessment
  • Current Challenges in Developing Biosimilars

Mail us at

Clinical Pharmacology-2017
clinicalpharmacology@alliedconferences.org
Clinical Pharmacology-2017
clinicalpharmacology@alliedmeet.com
Clinical Pharmacology-2017
clinicalpharmacology@alliedconference.com
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2017-2018 Allied Academies, All Rights Reserved.